top of page

Navigating the FDA's Guidelines for Variations in Pharmaceuticals

  • Writer: Jeremy Jakob
    Jeremy Jakob
  • Dec 1, 2023
  • 1 min read

This post contains a list of links giving access to the most relevant variation guidance published by FDA.


ree


Guidance "Changes to an approved NDA or ANDA"


ree

Guidance "Changes to an Approved NDA or ANDA: Questions and Answers"

ree

Guidance "CMC Postapproval Manufacturing Changes To Be Documented in Annual Reports"


ree

Draft Guidance "CMC Postapproval Manufacturing Changes for Specified Biological Products To Be Documented in Annual Reports" Link


ree

Guidance "Postapproval Changes to Drug Substances"


ree

Guidance "Variations in Drug Products that May Be Included in a Single ANDA"


ree


Guidance "PAC-ATLS: Postapproval Changes - Analytical Testing Laboratory Sites"


ree

Guidance "Changes to an Approved Application for Specified Biotechnology and Specified Synthetic Biological Products" (link)


ree

Guidance "Changes to an Approved Application: Biological Products" Link


ree



Comments


bottom of page